Semnur Pharmaceuticals Inc (SMNR)
Health CareSnapshot 2026-10-21
$0.50-9.02%
Close 2026-09-04 · 1-day change
Health CareSnapshot 2026-10-21
Research Workspace
Put SMNR beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
No standing thesis yet — not enough to read.
View ThesisThis stock is highly volatile — it swings about 7% on a typical day and fell roughly 98% in its worst 12-month stretch.
View RiskSMNR’s case rests on strong recent performance in a supportive healthcare sector. The earnings trend and latest result are unknown because no release is recorded. Its valuation cannot be compared: the desk has no multiple or peer valuation. Unsteady management, high risk, and past losses weaken confidence in the case. The desk has no miss probability or specific thesis-break alarm. Our standing thesis is not yet established. Peer-multiple valuation is unavailable; this read is provisional.
Trailing returns as of 2026-09-04. SMNR is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Continue this research
Compare SMNR with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| SMNR Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-10-21. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Health Care (broad) — fair value, gap to price, and forward P/E.
Compare the value case
Put SMNR next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.